Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.
Cytawa W, Hendel R, Tomasik B, Weinzierl FX, Bley T, Jassem J, Schirbel A, Buck AK, Bundschuh RA, Hartrampf PE, Werner RA, Lapa C. Cytawa W, et al. Among authors: weinzierl fx. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3765-3776. doi: 10.1007/s00259-023-06326-w. Epub 2023 Jul 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 37474735 Free PMC article.
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Hartrampf PE, Weinzierl FX, Buck AK, Rowe SP, Higuchi T, Seitz AK, Kübler H, Schirbel A, Essler M, Bundschuh RA, Werner RA. Hartrampf PE, et al. Among authors: weinzierl fx. Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3269-3276. doi: 10.1007/s00259-022-05744-6. Epub 2022 Mar 4. Eur J Nucl Med Mol Imaging. 2022. PMID: 35243517 Free PMC article.
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up.
Hartrampf PE, Seitz AK, Weinzierl FX, Serfling SE, Schirbel A, Rowe SP, Kübler H, Buck AK, Werner RA. Hartrampf PE, et al. Among authors: weinzierl fx. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4262-4270. doi: 10.1007/s00259-022-05853-2. Epub 2022 Jun 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 35650263 Free PMC article.
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
Hartrampf PE, Bundschuh RA, Weinzierl FX, Serfling SE, Kosmala A, Seitz AK, Kübler H, Buck AK, Essler M, Werner RA. Hartrampf PE, et al. Among authors: weinzierl fx. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4727-4735. doi: 10.1007/s00259-022-05910-w. Epub 2022 Jul 19. Eur J Nucl Med Mol Imaging. 2022. PMID: 35852555 Free PMC article.
Acute overdose of intrathecal baclofen.
Dressnandt J, Weinzierl FX, Tölle TR, Konstanzer A, Conrad B. Dressnandt J, et al. Among authors: weinzierl fx. J Neurol. 1996 Jun;243(6):482-3. doi: 10.1007/BF00900504. J Neurol. 1996. PMID: 8803823 No abstract available.